Laboratories that conduct EML4-ALK testing
Between 4% and 5% of lung cancer patients with adenocarcinoma histology have a genetic abnormality called the 'EML4-ALK gene fusion'. Patients with the EML4-ALK mutation can be effectively treated with medications that block ALK function, such as the recently approved Xalkori. The laboratories listed below offer testing for the EML4-ALK gene fusion.
| Vendor | Vendor Test/Assay Unique Identifier | Contact Information |
|---|---|---|
| Baylor College of Medicine | 8030 | (800) 411-GENE (4363), Fax (713) 798-2787 |
| GenPath Diagnostics | A241-2 | (800) 627-1479 |
| Molecular Pathology Laboratory Network | F ALK | (800) 932-2943 info@mplnet.com |
| Ohio State University, Pathology Core Facility (PCF) | ALK translocation | Call Aileen @ 614-293-5292, Aileen.Carter@osumc.edu |
| Quest Diagnostics | FISH for ALK 2p23 rearrangements | (800) 222-0446, http://www.questdiagnostics.com/hcp/contactus/hcp_contact_cust_srv.html |
| Response Genetics | EML4-ALK translocation | (323) 224-3900, (323) 224-3096 |
| University of Pittsburgh Medical Center, FISH Lab | ALK translocation | (412) 641-4168, (800) 454-8156 |
Our goal is to provide a comprehensive list of laboratories that conduct EML4-ALK mutational analysis.
If your company conducts this test but is not listed, Email Us.